Publikationen, an denen er mitarbeitet Fernando Aranda Vega (12)

2020

  1. Multifaceted effects of soluble human CD6 in experimental cancer models

    Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 1

2019

  1. Treatment of experimental autoimmune encephalomyelitis by sustained delivery of low-dose IFN-a

    Journal of Immunology, Vol. 203, Núm. 3, pp. 696-704

2017

  1. Erratum for Martínez-Florensa et al., "Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial Sepsis"

    Antimicrobial agents and chemotherapy

  2. Protective effects of human and mouse soluble scavenger-like CD6 lymphocyte receptor in a lethal model of polymicrobial sepsis

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 1

  3. Relevance of CD6-mediated interactions in the regulation of peripheral T-cell responses and tolerance

    Frontiers in Immunology, Vol. 8, Núm. MAY

2016

  1. Interferon alpha bioactivity critically depends on Scavenger receptor class B type I function

    OncoImmunology, Vol. 5, Núm. 8

  2. Vaccine-induced but not tumor-derived Interleukin-10 dictates the efficacy of Interleukin-10 blockade in therapeutic vaccination

    OncoImmunology, Vol. 5, Núm. 2

2015

  1. Liver-directed gene therapy of chronic hepadnavirus infection using interferon alpha tethered to apolipoprotein A-I

    Journal of Hepatology, Vol. 63, Núm. 2, pp. 329-336

2012

  1. Combinación de adyuvantes y bloqueo de mecanismos inmunosupresores como estrategias de vacunación terapéutica

    Combinación de adyuvantes y bloqueo de mecanismos inmunosupresores como estrategias de vacunación terapéutica

2011

  1. Adjuvant combination and antigen targeting as a strategy to induce polyfunctional and high-avidity T-cell responses against poorly immunogenic tumors

    Cancer Research, Vol. 71, Núm. 9, pp. 3214-3224

  2. Induction of monocyte chemoattractant protein-1 and interleukin-10 by TGFβ1 in melanoma enhances tumor infiltration and immunosuppression

    Cancer Research, Vol. 71, Núm. 3, pp. 812-821

2009

  1. Peptide inhibitors of transforming growth factor-β enhance the efficacy of antitumor immunotherapy

    International Journal of Cancer, Vol. 125, Núm. 11, pp. 2614-2623